Evidence map›Paper›PMID 39888664›Full record

ArticleMicrobiology (Reading, England)2025

Sequestration of dead-end undecaprenyl phosphate-linked oligosaccharide intermediate.

Yaoqin Hong, Jilong Qin, Matthew Thomas Doyle, Peter Richard Reeves

Abstract read
In one paragraph

Article in Microbiology (Reading, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yaoqin HongBiomedical Sciences and Molecular Biology, College of Medicine and Dentistry, James Cook University, Douglas, Queensland, Australia.
Jilong QinCentre for Immunology and Infection Control, Queensland University of Technology, Herston, Queensland, Australia.
Matthew Thomas DoyleCentre for Drug Discovery Innovation, The University of Sydney, Darlington, New South Wales, Australia.
Peter Richard ReevesSchool of Life and Environmental Sciences, The University of Sydney, Camperdown, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Most Gram-negative bacteria synthesize a plethora of cell surface polysaccharides that play key roles in immune evasion, cell envelope structural integrity and host-pathogen interactions. In the predominant polysaccharide Wzx/Wzy-dependent pathway, synthesis is divided between the cytoplasmic and periplasmic faces of the membrane. Initially, an oligosaccharide composed of 3-8 sugars is synthesized on a membrane-embedded lipid carrier, undecaprenyl pyrophosphate, within the cytoplasmic face of the membrane. This lipid-linked oligosaccharide is then translocated to the periplasmic face by the Wzx flippase, where it is polymerized into a repeat-unit polysaccharide. Structural alterations to the O-antigen repeating oligosaccharide significantly reduce polysaccharide yield and lead to cell death or morphological abnormalities. These effects are attributed to the substrate recognition function of the Wzx flippase, which we postulated to act as a gatekeeper to ensure that only complete substrates are translocated to the periplasmic face. Here, we labelled

Indexed as

OligosaccharidesPolyisoprenyl PhosphatesSalmonella typhimuriumBacterial ProteinsCell MembraneGalactoseO AntigensPeriplasmBacterial ProteinsGalactoseO AntigensOligosaccharidesPolyisoprenyl Phosphatesundecaprenyl phosphateO-antigenpolysaccharidesubstrate fidelitysubstrate preferenceundecaprenyl phosphateWzx flippase

Identifiers

PMID39888664
PMCPMC11784914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.